MIDTOWN UROLOGY ASSOCIATES

What MIDTOWN UROLOGY ASSOCIATES does

Midtown Urology Associates is a privately held, founder-owned urology medical practice headquartered at 911 West 38th Street, Suite 200, Austin, Texas, founded in 2005 by Dr. Michael Trotter after his urology residency at the University of New Mexico. The practice delivers comprehensive adult urological care — covering BPH, prostate cancer, kidney stones, erectile dysfunction, low testosterone, male infertility, vasectomy and reversal, bladder and testicular cancer, and female urology — to patients across the Austin metropolitan area, with revenue generated primarily through fee-for-service clinical consultations, in-office and hospital-based procedures, and insurance reimbursements from major plans including Medicare, BCBS, Aetna, Cigna, Humana PPO, United Healthcare, and others.

The practice's technology portfolio spans minimally invasive and robotic procedures: UroLift (with Dr. Trotter as the 10th UroLift Center of Excellence in the U.S. and 500+ cases performed), Aquablation Therapy, Rezum, HoLEP, iTind, Optilume, Echolaser transperineal laser ablation (first in Texas), Low-Intensity Shockwave Therapy, no-scalpel vasectomy, SpaceOAR hydrogel, and Bladder Botox. Operational technology includes an online scheduling system (Phreesia), a patient portal (Intrinsiq), and a PatientPop-built website. The practice also operates a sub-brand, KSPtabs, an over-the-counter effervescent kidney stone prevention supplement developed by Dr. Trotter and sold direct-to-consumer through a dedicated website, with revenue from this consumer health product disclosed separately from clinical services.

Commercially, Midtown pursues a sales-led, direct-to-patient go-to-market combining physician referrals, self-referrals, and digital marketing (Google/Yelp reviews, Facebook, Instagram, LinkedIn, blog content, video testimonials, YouTube). Clinical staff consists of two board-certified urologists (Dr. Trotter, Dr. McClintock) and three advanced practice providers (Andrew Barger APRN, Jesus Ibarra PA-C, Linda Thi APRN), supported by administrative staff for a total of 16 employees. The practice is also active in five device-manufacturer-sponsored clinical research studies (Rivermark, Olympus, Laborie, Procept, Rocamed), positioning it as a Central Texas research site for next-generation BPH and prostate cancer technologies.

Name

MIDTOWN UROLOGY ASSOCIATES

Legal name

Midtown Urology Associates

Website

https://austinmidtownurology.com

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

11–50 employees

Short description

Midtown Urology Associates is a privately held, founder-owned urology medical practice in Austin, Texas, founded in 2005, providing comprehensive adult urological care — BPH, prostate cancer, kidney stones, ED, vasectomy, and more — to Austin-area patients using minimally invasive procedures and an OTC kidney stone supplement, KSPtabs.

Ownership category

akta.pro rank

Product category

Urology Medical Practice

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

General Urology (HLAKAOAA)

akta.pro secondary industries

Endourology & Minimally Invasive Urologic Surgery (HLAKAOAF), Urolithiasis / Kidney Stone Centers (HLAKAOAG), Female Pelvic Medicine & Reconstructive Surgery (Urogynecology) (HLAKAOAC)

Keywords

• Urology medical services
• Men's health treatment
• Prostate care procedures
• Kidney stone management
• Urological diagnostics

Headquarters

HQ city

Austin

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Clinical Consultation and Procedure Services: Fee-for-service medical practice providing urological consultations, diagnostic services, and surgical/procedural treatments including vasectomies, BPH treatments, cancer treatments, and various urological procedures.
2. KSPtabs Supplement Sales: Sale of proprietary kidney stone prevention supplement KSPtabs, developed by Dr. Trotter. Available over-the-counter for proactive kidney health.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Midtown Urology Associates is a private urology medical practice in Austin, TX providing comprehensive diagnostic, in-office, and surgical urological care for adult men and women. Services span BPH treatment (UroLift, Aquablation, Echolaser TPLA, Rezum), prostate/bladder/testicular cancer treatment, kidney stone management, erectile dysfunction, low testosterone therapy, vasectomy and reversal, and female urology. The practice also sells KSPtabs, an over-the-counter kidney stone prevention supplement developed by founder Dr. Michael Trotter.

Product overview

Midtown Urology Associates is a comprehensive urology medical practice in Austin, TX offering a wide range of diagnostic and treatment services. The practice provides specialized care across multiple service lines including prostate health (BPH treatment with UroLift and Aquablation Therapy, prostate cancer treatment, SpaceOAR), kidney stone management (treatment procedures and KSPtabs supplement), men's health (low testosterone treatment, erectile dysfunction with shockwave therapy, vasectomy and reversal), bladder care (cancer treatment, Botox), and female urology. The practice also offers consumer health products like KSPtabs, an OTC kidney stone prevention supplement developed by Dr. Trotter. Services are provided by urologists Michael Trotter, MD, Tyler McClintock, MD, and advanced practice providers.

Differentiator

Problem solved

Functional benefit

Brands

• KSPtabs: Over-the-counter kidney stone prevention supplement developed by Dr. Trotter. Promotes hydration while providing natural stone inhibitors including potassium citrate, magnesium, and B6.

Products and services

• BPH (Benign Prostatic Hyperplasia) Treatment

Named customers4 records

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Five partnerships are on record, tiered minor.

• Rivermark MedicalminorStrategic or Co-development PartnerParticipating in Rivermark RAPID-III (Flostent) clinical study for an innovative prostate stent treatment. Flostent uses cardiac stent-inspired technology for urology, stenting open prostate blockage through a standard flexible office scope.
• OlympusminorStrategic or Co-development PartnerParticipating in Olympus MT-08 study comparing iTind vs Urolift for BPH treatment. iTind is a temporary tissue expander placed in prostate for one week.
• LaborieminorStrategic or Co-development PartnerParticipating in Laborie PEAK study for Optilume BPH treatment using balloon dilation of prostate channel. This is an OR-based procedure preserving ejaculatory function.
• ProceptminorStrategic or Co-development PartnerParticipating in Procept PRCT001 study applying Aquablation technology to treat prostate cancer. Aquablation uses robotically-controlled water jets to remove prostate tissue.
• RocamedminorStrategic or Co-development PartnerFirst urology practice in Texas to offer Rocamed Echolaser transperineal laser ablation (TPLA) for urinary symptoms. Minimally-invasive therapy placing needles through skin to apply laser energy reducing prostate size.

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• St. David's HealthCare: Major Austin-area hospital system that employs urologists and competes for inpatient and procedural urology volume in the same Austin market served by Midtown.

Direct peers

• Solaris Health: Leading urology platform formed by the merger of New Jersey Urology and Urology of Indiana, providing comprehensive urological care across multiple states and a direct PE-backed comparator in specialty urology consolidation.
• US Urology Partners: PE-backed urology practice consolidation platform founded in partnership with Cookridge, operating multi-state urology groups with comprehensive service lines analogous to Midtown's broad offering.
• Chesapeake Urology: Large independent urology group in the Mid-Atlantic region offering comprehensive urological care, advanced BPH treatments, and clinical research participation, comparable in scope and reputation profile.
• Austin Urology Institute: Austin-area urology practice offering similar BPH, ED, and general urological services; competes directly for self-referred and physician-referred patients in the Austin metro.
• United Urology Group: PE-backed urology group with multiple affiliated practices across the Mid-Atlantic and Western US, offering the same broad urological service mix and facing the same payer and competitive dynamics as Midtown.
• Advanced Urology Institute: Multi-physician urology group offering comprehensive urological services including advanced BPH treatments and clinical research participation across multiple locations.
• Urology Austin: Direct local Austin competitor offering similar comprehensive urological services; the most head-to-head competitive peer given shared geography and overlapping service mix.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/MidtownUrologyAustin
• LinkedInlinkedin.com/company/midtown-urology-associates
• Instagraminstagram.com/midtownurology

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MIDTOWN UROLOGY ASSOCIATES